Does Health Net Cover Ozempic?
The verdict
Conditional on most plans
Health Net covers Ozempic for type 2 diabetes with prior authorization — it does not cover Ozempic for off-label weight-loss use under any Health Net line of business. As a Centene subsidiary concentrated in California, Health Net administers Medi-Cal managed care, where Ozempic for T2D is covered under the California Medi-Cal preferred drug list with PA. For commercial plans, the standard T2D PA path applies. Formulary tier and specific cost-share are not publicly confirmed at the drug level.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Health Net using your member ID.
Key facts
Ozempic is FDA-approved for type 2 diabetes glycemic control and cardiovascular risk reduction in T2D patients — not for weight loss.
FDA drug labeling (semaglutide injection)
California Medi-Cal covers GLP-1s including Ozempic for type 2 diabetes; all 50 state Medicaid programs do so for T2D.
KFF, Medicaid Coverage of and Spending on GLP-1s
The IRA Maximum Fair Price for semaglutide under Medicare is $274 per 30-day supply, effective January 1, 2027.
CMS, IRA Drug Price Negotiation Program, 2024
Medicare vs. commercial coverage
Whether Health Net covers Ozempic depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
Medicare Advantage (Health Net CA Medicare): Ozempic is covered for type 2 diabetes with prior authorization. PA requires a documented T2D diagnosis and evidence of metformin step-therapy or a documented contraindication. The 2026 Part D out-of-pocket cap of $2,100 limits annual beneficiary spending on covered drugs. Medicare Advantage enrollees cannot use the NovoCare savings card — federal anti-kickback rules exclude Medicare and Medicaid beneficiaries. The IRA Maximum Fair Price for semaglutide is $274 per 30-day supply, effective January 1, 2027. Ozempic is not covered for weight loss under Medicare Advantage.
Commercial / Employer
Group & marketplace plans
Commercial/Employer (Health Net CA): Ozempic is covered for type 2 diabetes with prior authorization and metformin step-therapy. Formulary tier is not publicly confirmed at the drug level — verify on Health Net's drug-lookup tool or call member services. Commercially insured T2D patients may be eligible for the NovoCare Ozempic Savings Card ($25 per fill, max $150 per 28-day supply) — verify at NovoCare.com. Not covered for off-label weight loss. ACA/Individual: covered for T2D with PA; not covered for weight loss. California's weight-loss GLP-1 coverage landscape is restricted — Blue Shield of California limited Wegovy new starts to BMI ≥40 effective 2025 — but that is a weight-loss policy unrelated to Ozempic's T2D coverage at Health Net. Medicaid (Medi-Cal, Health Net California Medi-Cal): Ozempic is covered for type 2 diabetes under the California Medi-Cal preferred drug list with prior authorization. Nominal Medi-Cal cost-share ($1–$3 copay for covered drugs). Not covered for off-label weight loss. Medi-Cal enrollees cannot use the NovoCare savings card.
The 3 boxes you must tick to get approved
Commercial plans that will consider Ozempic require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
Meet all 3 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Ozempic actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
~$1,028/month (Novo Nordisk published pricing, ~$1,027.51 for the 0.25/0.5 mg pen). NovoCare self-pay: ~$199/month intro price (first two fills through December 31, 2026), then ~$349/month (0.25/0.5/1 mg) or ~$499/month (2 mg).
List price with no coverage — before any manufacturer savings card.
With coverage
Commercial: plan-specific cost-share — verify on Health Net drug-lookup tool. Medi-Cal: nominal $1–$3 copay for covered T2D use. Medicare Advantage: cost-share depends on plan tier; $2,100 Part D OOP cap applies in 2026. IRA Maximum Fair Price of $274/30-day for semaglutide takes effect January 1, 2027 for Medicare enrollees.
Typical monthly copay once prior authorization is approved.
Bridge program
NovoCare Ozempic Savings Card: commercially insured T2D patients may pay as little as $25 per fill (max $150 per 28-day supply). Not available to Medi-Cal, Medicare, VA, DoD, or TRICARE beneficiaries. Verify eligibility at NovoCare.com.
Reduced copay through the assistance program, where eligible.
All figures are estimates — verify exact cost-share with Health Net member services or on your plan's drug-lookup tool. Tier placement and cost-share vary by specific Health Net plan and line of business.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Look up Ozempic on Health Net's formulary tool
Log in to your Health Net member account at healthnet.com and use the drug-lookup or formulary tool to confirm Ozempic's tier and any prior-authorization or step-therapy requirements on your specific plan. Commercial, Medi-Cal, and Medicare Advantage plans have different formulary structures.
- 2
Have your prescriber submit the prior-authorization request
Ask your provider to submit a PA request to Health Net documenting: a T2D diagnosis (ICD-10 E11.x), evidence of metformin use or a documented contraindication, and any additional oral-agent step-therapy required by your plan. The clinical indication must be type 2 diabetes — not weight management.
- 3
Check Medi-Cal PDL status and savings-card eligibility
If you are on Medi-Cal through Health Net, verify your plan's current preferred drug list for Ozempic T2D coverage. If you are on a commercial plan, ask your pharmacist about the NovoCare $25 savings card. If on Medicare Advantage, note the IRA price of $274/30-day for semaglutide effective January 1, 2027. Call Health Net member services for a personalized cost estimate.
Options if Health Net won't cover Ozempic
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
Rybelsus (oral semaglutide)
Oral semaglutide tablet for type 2 diabetes. Also covered for T2D on most formularies with PA. Subject to the IRA Maximum Fair Price of $274/30-day effective January 1, 2027 for Medicare patients. Verify tier on Health Net drug-lookup.
Jardiance (empagliflozin)
SGLT-2 inhibitor commonly used as step-therapy oral agent before GLP-1 approval. Often at a lower cost-share tier than Ozempic on commercial and Medi-Cal formularies.
Metformin (generic)
First-line oral diabetes medication universally covered at low or no cost on commercial and Medi-Cal plans. Required as step therapy before Ozempic PA approval in most plans.
Compounded semaglutide (weight-loss seekers only)
For California patients seeking semaglutide for weight management who are denied by Health Net, compounded semaglutide from $49/mo is available at getcurex.com/cl/glp without insurance. See the Curex offer section below for full disclaimers.
These options are listed for information only — your own clinician decides what is appropriate for you.
❓Frequently Asked Questions
No. Health Net does not cover Ozempic for weight loss under any line of business. Ozempic holds FDA approval only for type 2 diabetes and cardiovascular risk reduction in T2D patients — not for chronic weight management. Off-label weight-loss use is not covered on any Health Net commercial, ACA, Medi-Cal, or Medicare Advantage plan. California's GLP-1 weight-loss landscape has become more restrictive (Blue Shield of California limited Wegovy to BMI ≥40), but regardless, Ozempic for weight loss is not covered at Health Net or any insurer.
Yes. California Medi-Cal covers Ozempic for type 2 diabetes under its preferred drug list with prior authorization, and Health Net administers Medi-Cal managed care in California. Medi-Cal enrollees pay a nominal copay ($1–$3 typical) for covered T2D use. Medi-Cal beneficiaries cannot use the NovoCare savings card. The T2D indication is covered; off-label weight-loss use is not covered under any Medi-Cal program or Health Net Medi-Cal plan.
Health Net commercial plan enrollees with a T2D diagnosis may be eligible for the NovoCare Ozempic Savings Card ($25 per fill, max $150 per 28-day supply) — verify eligibility at NovoCare.com. Medi-Cal and Medicare Advantage enrollees cannot use the savings card; federal anti-kickback rules exclude government program beneficiaries. If you are on a Health Net Medi-Cal or Medicare plan, you cannot use this card.
Health Net requires prior authorization for Ozempic with a documented type 2 diabetes diagnosis (ICD-10 E11.x) and evidence of metformin step-therapy or a documented medical contraindication. Specific PA criteria are not publicly confirmed in a primary Health Net document at the drug level — ask your prescriber to review your plan's current PA requirements via Health Net's PA portal or by calling member services before submitting.
Health Net follows the standard T2D-covered pattern for Ozempic — covered with prior authorization for type 2 diabetes, not covered for off-label weight loss — consistent with all other California insurers. Where Health Net differs is its Centene corporate ownership and Medi-Cal managed-care role: Medi-Cal enrollees access Ozempic through the California state PDL via Health Net's Medi-Cal plan. Commercial formulary details are not publicly confirmed at the drug level; verify on Health Net's drug-lookup tool.
Related Articles
Does Geisinger Health Plan Cover Mounjaro? 2026 Guide | Curex
Geisinger covers Mounjaro for type 2 diabetes with prior auth — not weight loss. PA Medicaid is diabetes-only after the 2025 weight-loss GLP-1 cut.
Read moreDoes Harvard Pilgrim Health Care Cover Ozempic? 2026 | Curex
Harvard Pilgrim covers Ozempic for type 2 diabetes with prior auth, not weight loss. NE Point32Health plan; T2D unaffected by GLP-1 weight-loss cuts.
Read moreDoes Harvard Pilgrim Health Care Cover Mounjaro? 2026 | Curex
Harvard Pilgrim (Point32Health) covers Mounjaro for type 2 diabetes with PA — not weight loss. MA Medicaid covers diabetes; weight-loss GLP-1s restricted.
Read moreDoes Geisinger Health Plan Cover Ozempic? 2026 Guide | Curex
Geisinger covers Ozempic for T2D with PA — not weight loss. Risant/Kaiser ownership does not import Kaiser SGLT-2 step. Verify on Geisinger drug lookup.
Read moreDoes Health Net Cover Mounjaro? California 2026 | Curex
Health Net (Centene, CA) covers Mounjaro for type 2 diabetes with prior auth — not weight loss. Medi-Cal excludes weight-loss GLP-1s from 1/1/2026.
Read moreDoes Group Health Cooperative Cover Mounjaro? 2026 | Curex
Group Health Cooperative (GHC, WI) covers Mounjaro for type 2 diabetes with prior auth — not weight loss. Composite; verify on plan formulary.
Read moreInsurance won't cover Ozempic for weight loss — here's a path that doesn't need it
Health Net does not cover Ozempic for weight loss — and California's GLP-1 weight-loss coverage has grown more restrictive, not less. For California patients seeking semaglutide for weight management without insurance coverage, Curex offers compounded semaglutide starting at $49/mo with no prior authorization needed. Compounded tirzepatide is also available from $149/mo. Compounded semaglutide is not the same medication as Ozempic or Wegovy. Prescription required, subject to provider review.
- Medication + free shipping
- 24/7 provider access
- Medical intake & prescription review
Compounded semaglutide and tirzepatide are not the same medications as Ozempic and are not branded or FDA-approved products. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.
This content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Health Net before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation. Curex offers compounded semaglutide and tirzepatide, which are not the same medications as Ozempic and are not branded or FDA-approved products; prescription required, subject to provider review. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.